Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 6:45 pm Purchase | 13G | THIRD HARMONIC BIO INC THRD | EcoR1 Capital LLC | 3,182,444 7.9% | 200,000 (+6.71%) | View |
| 2024-02-13 4:33 pm Sale | 13G | THIRD HARMONIC BIO INC THRD | Stonepine Capital Management LLC | 0 0% | -2,152,968 (Position Closed) | View |
| 2023-11-27 4:30 pm Purchase | 13G | THIRD HARMONIC BIO INC THRD | RA CAPITAL MANAGEMENT L.P. | 2,033,056 5% | 1,498,369 (+280.23%) | View |
| 2023-09-13 5:02 pm Purchase | 13G | THIRD HARMONIC BIO INC THRD | EcoR1 Capital LLC | 2,982,444 7.4% | 2,982,444 (New Position) | View |
| 2023-02-14 4:45 pm Purchase | 13G | THIRD HARMONIC BIO INC THRD | RA CAPITAL MANAGEMENT L.P. | 534,687 1.3% | 534,687 (New Position) | View |
| 2023-02-14 06:31 am Sale | 13G | THIRD HARMONIC BIO INC THRD | Bain Capital Life Sciences Investors LLC | 1,151,657 2.8% | -1,128,425 (-49.49%) | View |
| 2023-02-08 4:30 pm Purchase | 13G | THIRD HARMONIC BIO INC THRD | Novartis Institutes for BioMedical Research Inc. | 2,642,762 6.5% | 2,642,762 (New Position) | View |
| 2023-01-18 6:03 pm Purchase | 13G | THIRD HARMONIC BIO INC THRD | Stonepine Capital Management LLC | 2,152,968 5.3% | 2,152,968 (New Position) | View |
| 2022-12-21 4:40 pm Purchase | 13G | THIRD HARMONIC BIO INC THRD | BIOTECHNOLOGY VALUE FUND L P | 4,365,933 10.8% | 864,119 (+24.68%) | View |
| 2022-09-29 4:44 pm Purchase | 13G | THIRD HARMONIC BIO INC THRD | Bain Capital Life Sciences Investors LLC | 2,280,082 5.7% | 2,280,082 (New Position) | View |
| 2022-09-29 4:30 pm Purchase | 13D | THIRD HARMONIC BIO INC THRD | Atlas Venture Fund XI L.P. | 10,313,763 25.6% | 10,313,763 (New Position) | View |
| 2022-09-28 4:23 pm Purchase | 13D | THIRD HARMONIC BIO INC THRD | ORBIMED ADVISORS LLC | 5,779,071 14.3% | 5,779,071 (New Position) | View |
| 2022-09-28 12:28 pm Purchase | 13D | THIRD HARMONIC BIO INC THRD | GENERAL ATLANTIC L.P. | 2,958,762 7.3% | 2,958,762 (New Position) | View |
| 2022-09-26 4:57 pm Purchase | 13G | THIRD HARMONIC BIO INC THRD | BIOTECHNOLOGY VALUE FUND L P | 3,501,814 9.1% | 3,501,814 (New Position) | View |
| 2022-09-26 4:29 pm Purchase | 13G | TF FINANCIAL CORP THRD | RA CAPITAL MANAGEMENT L.P. | 3,475,687 8.62% | 3,475,687 (New Position) | View |